System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Studies

Interventional Not yet recruiting

NCT07237178 on ClinicalTrials.gov

PROMBot-HSM-FA: Protocol for a Feasibility Study of a Chatbot Platform to Collect Patient-reported Outcomes After AF Ablation

Official title: PROMBot-HSM-FA: Protocol for a Feasibility Study of a Chatbot-based Platform to Collect Patient-reported Outcomes After Atrial Fibrillation Ablation

  • Sponsor: Ana Rita Londral, PhD
  • Enrollment: 76 (Estimated)
  • Study start: 2025-12-01 (Estimated)
  • Primary completion: 2026-04-01 (Estimated)
  • Study completion: 2027-12-01 (Estimated)
  • Allocation: Randomized
  • InterventionModel: Parallel
  • InterventionModelDescription: Patients undergoing catheter ablation for AF will be randomly assigned in a 1:1 ratio to receive either chatbot-supported follow-up through the PROMBot-FA platform (intervention group) or standard care (control group).
  • Masking: None
  • PrimaryPurpose: Supportive Care

Brief Summary

The goal of this clinical trial is to learn if using a WhatsApp-based chatbot called PROMBot-FA can help people recover after atrial fibrillation ablation. The main questions it aims to answer are:

* Is the chatbot easy and practical for people to use after their procedure?
* Do people find the chatbot helpful for sharing their symptoms and health updates?

Researchers will compare follow-up care supported by the chatbot to standard hospital follow-up visits. Participants will:

* Be randomly assigned to either use the chatbot or receive usual follow-up care.
* Report their symptoms, well-being, and any problems after ablation for 3 months.
* Complete short questionnaires about their experience using the chatbot.

This study will help researchers understand whether chatbot follow-up is feasible and acceptable for people after atrial fibrillation ablation and guide future larger studies.

Conditions

  • Atrial Fibrillation (AF)
  • Catheter Ablation

Intervention / Treatment

  • Behavioral: PROMBot-FA Chatbot-Supported Follow-Up
  • Other: Standard Care (in control arm)

Primary Outcome Measures

  • Engagement rate (3 months post-ablation)
    Proportion of expected patient-reported outcomes and biosignal entries successfully collected through the chatbot platform over the 3-month monitoring period.
  • Retention Rate at 3 Months (3 months post-ablation)
    Proportion of participants completing 3-month follow-up assessments among those initially enrolled.

Study Officials